FDA Inspection
Implant Direct Sybron International, LLCImplant Direct Sybron International, LLC – FDA Inspection, Aug 29, 2016
Record Details
This FDA Inspection record concerns Implant Direct Sybron International, LLC, with an inspection on August 29, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 29, 2016
- Product Type
- Biologics
View Company Profile
ID · eb18bade-1e60-46b3-a5fa-daf5a2103e14
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 988719
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Implant Direct Sybron International, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 3, 2018 | Not classified | San Francisco District Office | |
| September 26, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 28, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| August 7, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Implant Direct Sybron International, LLC
- FDA Inspection 1116461 - 2018-10-03
- FDA Inspection 1028754 - 2017-09-26
- FDA Inspection 982340 - 2016-06-28
- FDA Inspection 891481 - 2014-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.